Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium.

Literature DB >> 8308131

Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium.

Abstract

Growth of Legionella spp. on buffered charcoal yeast extract medium supplemented with alpha-ketoglutarate and formulated with 3-(n-morpholino)propanesulfonic acid (MOPS), 3-(n-morpholino)-2-hydroxypropanesulfonic acid (MOPSO), or n-(2-acetamido)-2-aminoethanesulfonic acid (ACES) buffer was similar. With three exceptions, growth was no different in buffered yeast extract broth supplemented with alpha-ketoglutarate and formulated with MOPS or ACES buffer.

Entities: Chemical Species

Mesh：

Substances：

Year: 1993 PMID： 8308131 PMCID： PMC266422 DOI： 10.1128/jcm.31.12.3329-3330.1993

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

4 in total

1. Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens.

Authors: P H Edelstein
Journal: J Clin Microbiol Date: 1981-09 Impact factor: 5.948

2. Influence of growth temperature on virulence of Legionella pneumophila.

Authors: P H Edelstein; K B Beer; E D DeBoynton
Journal: Infect Immun Date: 1987-11 Impact factor: 3.441

3. Pittsburgh pneumonia agent: direct isolation from human lung tissue.

Authors: A W Pasculle; J C Feeley; R J Gibson; L G Cordes; R L Myerowitz; C M Patton; G W Gorman; C L Carmack; J W Ezzell; J N Dowling
Journal: J Infect Dis Date: 1980-06 Impact factor: 5.226

4. Comparison of different agars used in the formulation of buffered charcoal yeast extract medium.

Authors: P H Edelstein; M A Edelstein
Journal: J Clin Microbiol Date: 1991-01 Impact factor: 5.948

4 in total

16 in total

1. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.

Authors: Paul H Edelstein; Baofeng Hu; Martha A C Edelstein
Journal: Antimicrob Agents Chemother Date: 2005-06 Impact factor: 5.191

2. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila.

Authors: Morikazu Akamine; Futoshi Higa; Noriko Arakaki; Kazuyoshi Kawakami; Kiyoshi Takeda; Shizuo Akira; Atsushi Saito
Journal: Infect Immun Date: 2005-01 Impact factor: 3.441

3. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.

Authors: P H Edelstein; M A Edelstein
Journal: Antimicrob Agents Chemother Date: 1999-01 Impact factor: 5.191

4. Comparison of the plating efficiencies and shelf lives of three different commercial buffered charcoal yeast extract media supplemented with alpha-ketoglutaric acid.

Authors: Paul H Edelstein; Martha A C Edelstein
Journal: J Clin Microbiol Date: 2010-03-03 Impact factor: 5.948

5. Identification of Legionella pneumophila genes important for infection of amoebas by signature-tagged mutagenesis.

Authors: A H Polesky; J T Ross; S Falkow; L S Tompkins
Journal: Infect Immun Date: 2001-02 Impact factor: 3.441

6. Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model.

Authors: P H Edelstein; M A Edelstein; F Higa; S Falkow
Journal: Proc Natl Acad Sci U S A Date: 1999-07-06 Impact factor: 11.205

7. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.

Authors: P H Edelstein; F Higa; M A Edelstein
Journal: Antimicrob Agents Chemother Date: 2001-10 Impact factor: 5.191